Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

ICU: No Harm Seen With Shortage-Fueled Switch

January 21, 2014 By Ed Susman

When fentanyl was in short supply, switching to hydromorphone did not adversely affect critically ill patients on mechanical ventilation, researchers reported here.

The median time on ventilation — a co-primary endpoint — was 8 days among the patients treated with hydromorphone versus 7 days for those treated with fentanyl (P=0.69), said Alison Vo, PharmD, a clinical care pharmacist at St. Luke’s Medical Center, Houston.

For the other primary endpoint, the rate of performing tracheostomies was 14 percent among those patients on hydromorphone and 19 percent among those patients treated with fentanyl (P=0.52), Vo reported in her poster presentation at the annual meeting of the Society of Critical Care Medicine.

Additionally, Vo told MedPage Today that there was no statistical difference in the number of days on opioid therapy — 6 days with hydromorphone and 4 days with fentanyl (P=0.18), and there was no difference in cumulative opioid dose, a median of 430 mg of morphine equivalents among the patients receiving hydromorphone and a median of 464 mg of morphine equivalents among the patients treated with fentanyl (P=0.25).

“We were specifically looking to see if there were any negative outcomes,” she said. “We also did look at hospital length of stay, and there were no differences there either. Numerically there appears to be greater use of rescue medication in the patients on hydromorphone, but when you group the need for rescue medication together there are no statistical differences,” she said.

“There were no differences in our clinical endpoints and that was something we were hoping to see — that we were not doing any harm to our patients,” Vo said.

During the poster discussion session, moderator Steven Blau, MD, critical care surgeon at Good Samaritan Hospital Medical Center, West Islip, New York, asked, “If there was no shortage of fentanyl, which drug would you prefer?” Vo said she would still opt to use fentanyl. Blau persisted, “Under what circumstances would you use hydromorphone instead of fentanyl?” Vo said that if a patient had several organ dysfunctions, she might consider hydromorphone instead of fentanyl.

Continue reading…

Related Articles Read More >

A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A portrait of Stryker executive Tracy Robertson
Stryker leaders talk medtech trends at DeviceTalks Boston: ‘If you’re slow, you’re going to lose’
gBETA Medtech accelerator picks its next startups
Titan Medical
Titan Medical inks a $2.6M purchase order from Medtronic

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech